Téma: MOLEKULOVÁ PATOLÓGIA NÁDOROVÝCH OCHORENÍ I.
Číslo abstraktu: 013
Autoři: Mgr. Jan Bouchal; Mgr. Dana Šimková; MUDr. Gvantsa Kharaishvili; Mgr. Tomáš Oždian (Odzian); MUDr. Tomáš Soukup (1980-), Ph.D.; Mgr. Michal Křupka, Ph.D.; Ing. Adéla Galandáková, Ph.D.; MUDr. Petr Džubák; Mgr. Alena Mičková; Mgr. Gabriela Kořínková, Ph.D.
Asporin belongs to small leucine rich proteoglycans family and its crucial characteristic is ability to bind collagens and initiate their mineralization. Asporin plays important role in normal development, in particular of cartilage, bone and teeth. Although asporin can now be found in multiple cancer related studies, its role in breast cancer is not clear. We have performed in silico search and found Hs578T breast cancer cell line with asporin expression which we confirmed by quantitative RT- PCR and western blotting. Human dental pulp stem cells were used for validation of asporin antibodies. Out of multiple testing, we found that asporin can be downregulated by bone morphogenetic protein 4 (BMP4) while upregulation may be facilited by serum-free cultivation or by three dimensional growth in stiff Alvetex scaffold. Downregulation by shRNA inhibited invasion of Hs578T through collagen type I matrix while adhesion and spheroid growth were not affected. Invasion of asporin-negative MDA-MB-231 and BT549 breast cancer cells through collagen type I was enhanced by recombinant asporin. In line with other studies, we have confirmed asporin expression by RNA scope in situ hybridization in cancer associated fibroblasts in invasive breast cancer. We haven't found any reliable antibody for immunohistochemistry. In conclusion, asporin expression may be regulated by different stimuli from tumor microenvironment, such as 3D culture, starvation or BMP4, which may in turn modulate extracellular matrix and invasion of breast cancer.
Datum přednesení příspěvku: 4. 6. 2016